These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2973747)

  • 21. Endothelin and atrial natriuretic peptide in non-insulin-dependent diabetic versus nondiabetic patients on chronic hemodialysis.
    Schleiffer T; Nagel D; Franz H; Falk M; Valentiner I; Wildburg G; Stark M; Brass H
    Ren Fail; 1994 Nov; 16(6):747-58. PubMed ID: 7899586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis.
    Ishikura F; Ando Y; Park YD; Tani A; Shirai D; Matsuoka H; Miyatake K
    Ren Fail; 1996 Mar; 18(2):261-70. PubMed ID: 8723364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
    Haug C; Metzele A; Steffgen J; Grünert A
    Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and long-term changes in plasma levels of atrial natriuretic factor in patients with renal replacement therapy.
    Nyberg G; Herlitz H; Björck S; Karlberg I; Hedner T; Hedner J
    Transpl Int; 1990 Dec; 3(4):195-8. PubMed ID: 2150168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma atrial natriuretic peptide during hemodialysis with or without fluid removal.
    Shiota J; Kubota M; Hamada C; Koide H
    Nephron; 1990; 55(3):283-6. PubMed ID: 2142515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Nielsen AL; Lindberg BF
    Nephron; 1994; 68(4):427-32. PubMed ID: 7870226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
    Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial natriuretic factor increases peritoneal dialysis efficiency in nephrectomized rats.
    Bianciotti LG; Vatta MS; Bengochea LA; Puyo AM; Fernandez BE
    Peptides; 1996; 17(1):87-92. PubMed ID: 8822515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis.
    Zoccali C; Mallamaci F; Ciccarelli M; Parlongo S; Salnitro F
    Clin Nephrol; 1992 Apr; 37(4):198-203. PubMed ID: 1533821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentration of atrial natriuretic polypeptide in chronic hemodialysis patients.
    Yamamoto Y; Higa T; Kitamura K; Tanaka K; Kangawa K; Matsuo H
    Regul Pept Suppl; 1985; 4():110-2. PubMed ID: 2932774
    [No Abstract]   [Full Text] [Related]  

  • 33. Human atrial natriuretic factor and renin-aldosterone in paracetamol induced fulminant hepatic failure.
    Panos MZ; Anderson JV; Forbes A; Payne N; Slater JD; Rees L; Williams R
    Gut; 1991 Jan; 32(1):85-9. PubMed ID: 1825077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
    Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
    Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial and brain natriuretic peptides in cardiovascular diseases.
    Naruse M; Takeyama Y; Tanabe A; Hiroshige J; Naruse K; Yoshimoto T; Tanaka M; Katagiri T; Demura H
    Hypertension; 1994 Jan; 23(1 Suppl):I231-4. PubMed ID: 8282365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digitalislike immunoreactive substances and extracellular fluid volume status in chronic hemodialysis patients.
    Bisordi JE; Holt S
    Am J Kidney Dis; 1989 May; 13(5):396-403. PubMed ID: 2541609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease. Effect of hemodialysis.
    Elias AN; Vaziri ND; Maksy M
    Arch Intern Med; 1985 Jun; 145(6):1013-5. PubMed ID: 4004425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis.
    Korzets Z; Pomeranz M; Shilo L; Pomeranze A; Levi A; Shenkman L; Berheim J
    Adv Perit Dial; 1989; 5():20-3. PubMed ID: 2577411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
    Jespersen B; Pedersen EB
    Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long and short hemodialysis on endothelial function: a short-term study.
    McGregor DO; Buttimore AL; Lynn KL; Yandle T; Nicholls MG
    Kidney Int; 2003 Feb; 63(2):709-15. PubMed ID: 12631138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.